VITAMIN C TEVA 1G

VITAMIN C TEVA

active ingredients

Each effervescent tablet contains: Active ingredient: ascorbic acid mg 1000. Excipients with known effects: sucrose, sodium, aspartame, coloring E 110 (sunset yellow) and coloring E 102 (tartrazine). For the full list of excipients, see paragraph 6.1.

Excellent

Each tablet contains: Excipients: sodium bicarbonate, sucrose, tartaric acid, citric acid, leucine, aroma citronjus, sodium chloride, sodium saccarin, aspartame, coloring E 110 (yellow sunset), coloring E 102 (tartrazine).

Therapeutic indications

Famineous states from ascorbic acid (gravity, lactation, increased vitamin requirements).

Contraindications

Hypersensitivity to the active ingredient, to other substances strictly related to the chemical or to any of the excipients listed in the paragraph 6.1. The administration of ascorbic acid by mouth is contraindicated in case of diarrhea or other gastrointestinal disorders.

Population

Population Administer from 1 to 3 tablets daily in a glass of water. Method of administration For oral use. Dissolve an effervescent tablet in a glass of water and immediately drink the solution obtained.

Conservation

Keep the container well closed to protect the medicine from moisture. In fact the effervescent tablets are sensitive to moisture and in the container cap there is a drying substance that serves to protect the moisture tablets that could penetrate you. Store at a temperature below 25°C.

Warnings

Ascorbic acid should be given with caution in patients with hyperoxluria. Vitamin C must be used with caution by individuals who suffer, or have suffered in the past, nephrolitiases (renal calculosis) and those suffering from G6PD Deficit (glucose-6-phosphatededrogenase), hemochromatosis, thalassaemia or sideroblastic anemia. Ascorbic acid can alter, at high doses, the results of the most common diagnostic tests, in particular for glycosuria, with non-specific means, giving falsely positive results. It is therefore advisable to suspend the intake of the product a few days before proceeding to the dosage of glucose in the urine. Do not use for protracted treatments. This medicine contains: • sucrose; patients suffering from rare hereditary problems of fructose intolerance, glucose-galactosis mal absorption, or isomaltase sucrasis failure, should not take this medicine. • about 12.5 mmol (or 287 mg) sodium for effervescent tablet. To be considered in people with reduced kidney function or following a low sodium diet. • aspartame: a source of phenylalanine. It can be harmful to patients suffering from phenylchetonuria. • coloring E 110 (sunset yellow) and coloring E 102 (tartrazina): can cause allergic reactions.

Interactions

Ascorbic acid can increase the apparent half-life of paracetamol. Concurrent administration of antacids containing aluminum can increase the elimination of aluminum through urine. Concurrent administration of antacids and ascorbic acid is not recommended, especially in patients with kidney failure. Concurrent administration of ascorbic acid and deferoxamine increases urinary excretion of iron. Cases of cardiomyopathy and congestive heart failure have been reported in patients with idiopathic hemochromatosis and thalassaemia, in treatment with deferoxamine, subsequently treated with ascorbic acid. In these patients ascorbic acid must be used with caution and their heart function must be monitored.

Effects

Ascorbic acid is generally well tolerated. High doses can cause diarrhea and formation of kidney stones of calcium oxalate. You can experience nausea and stomach cramps. In prepared subjects, hypersensitivity reactions can occur. At higher dosages than recommended, headaches and gastrointestinal disorders were reported. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

If ascorbic acid is administered in excess of the body’s demands, the unused rate is eliminated with urine: there is no danger of overdose. Nevertheless, occasionally very high amounts of ascorbic acid can determine slight gastrointestinal disorders consisting mainly of laxative type phenomena. In such cases, treatment should be stopped. Ascorbic acid can cause acidosis or hemolytic anemia in some individuals with glucose-6-phosphate dehydrogenase deficiency. In case of massive overdose of ascorbic acid, kidney failure may occur.

Pregnant and breastfeeding administration is among the therapeutic indications. Unless otherwise prescribed, it is recommended not to exceed the dose of 1 g/day.

Source: Farmadati